You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 272 No. 10, September 14, 1994 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sclerodermalike Esophageal Disease in Children of Mothers With Silicone Breast Implants

Merry Liau; Shinya Ito, MD; Gideon Koren, MD
Motherisk Program Hospital for Sick Children Toronto, Ontario

JAMA. 1994;272(10):769.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Silicone breast implants have recently come under scrutiny because of the portrayal of the perceived risk associated with silicone breast implants by the media and popular press. Our interest in this subject began with inquiries to our antenatal clinic for drug and chemical risk counseling (the Motherisk Program) from individuals who were concerned about the potential effect of breast-feeding their infants while having silicone breast implants. Recent findings of sclerodermalike esophageal disease in children breast-fed by mothers with silicone breast implants1 have raised questions about whether significant amounts of silicone are excreted in milk. However, no published data are available to date.

We analyzed human milk for silicon concentrations in three women: two women with silicone gel breast implants and one control woman without silicone implants. The technique of inductively coupled plasma emission spectrometry2 with a detection limit of 0.5 mg/L was used for the . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.